Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy.

Saved in:
Bibliographic Details
Title: Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy.
Authors: Spadotto V; New Drug Incubator Department, Italfarmaco Group, Milan, Italy., Ripamonti C; New Drug Incubator Department, Italfarmaco Group, Milan, Italy., Ghiroldi A; New Drug Incubator Department, Italfarmaco Group, Milan, Italy., Galbiati E; Preclinical Drug Development Department, Italfarmaco Group, Milan, Italy., Pozzi P; Preclinical Drug Development Department, Italfarmaco Group, Milan, Italy., Noberini R; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Bonaldi T; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy., Steinkühler C; New Drug Incubator Department, Italfarmaco Group, Milan, Italy., Fossati G; New Drug Incubator Department, Italfarmaco Group, Milan, Italy.
Source: Frontiers in immunology [Front Immunol] 2025 Aug 05; Vol. 16, pp. 1645773. Date of Electronic Publication: 2025 Aug 05 (Print Publication: 2025).
Publication Type: Published Erratum
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1645773